Hangzhou, China, Oct. 10, 2025 (GLOBE NEWSWIRE) — WORK Medical Know-how Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Firm”), a provider of medical gadgets in China, by means of its subsidiary, Work (Hangzhou) Medical Remedy Gear Co., Ltd. and its subsidiaries in China, in the present day introduced that it has acquired a notification letter from the Nasdaq Inventory Market LLC (“Nasdaq”) granting the Firm an extra 180-calendar-day interval to regain compliance with the minimal bid value requirement pursuant to Nasdaq Itemizing Rule 5550(a)(2) (the “Rule”).
The notification follows Nasdaq’s preliminary discover on April 7, 2025, which said that WORK Medical’s inventory had failed to satisfy the minimal bid value requirement over a interval of 30 consecutive enterprise days, and supplied WORK Medical an preliminary compliance interval of 180 calendar days to regain compliance. The preliminary compliance interval expired on October 6, 2025.
In keeping with the letter issued by Nasdaq on October 7, 2025, WORK Medical is eligible for an extra compliance interval till April 6, 2026, because the Firm continues to satisfy all different relevant itemizing necessities for the Nasdaq Capital Market, aside from the bid value rule. The Firm has knowledgeable Nasdaq of its intention to remedy the deficiency, together with, if obligatory, by the implementation of a reverse inventory break up.
To regain compliance with the Rule, WORK Medical’s inventory should obtain a minimal closing bid value of $1.00 per share for at the very least 10 consecutive enterprise days throughout the further compliance interval. Nasdaq has discretion to require the bid value to be maintained for an extended interval, as much as 20 days, relying on components comparable to margin of compliance, buying and selling quantity, and the Market Maker montage.
If WORK Medical fails to regain compliance with the Rule by April 6, 2026, Nasdaq will situation a proper notification of delisting. In such a state of affairs, the Firm might attraction the willpower to a Nasdaq Hearings Panel.
The October 7, 2025 notification from Nasdaq has no fast impact on the itemizing or buying and selling of the Firm’s Class A abnormal shares, which can proceed to commerce on the Nasdaq Capital Market below the image “WOK.”
About WORK Medical Know-how Group LTD
WORK Medical Know-how Group LTD, by means of its subsidiary, Work (Hangzhou) Medical Remedy Gear Co., Ltd. and its subsidiaries in China, is a provider of medical gadgets that develops and manufactures Class I and II medical gadgets and sells Class I and II disposable medical gadgets by means of working subsidiaries in China. The Firm has a various product portfolio comprising 21 merchandise, together with custom-made and multifunctional masks and different medical consumables. All of the merchandise have been offered in 34 provincial-level administrative areas in China, with 15 of them offered in additional than 30 international locations worldwide. The Firm has acquired quite a lot of quality-related manufacturing designations and has registered 17 merchandise with the U.S. Meals and Drug Administration permitting their merchandise to enter the U.S. market. For extra data, please go to the Firm’s web site:
https://www.workmedtech.com/corporate
.
Ahead-Wanting Statements
This press launch comprises forward-looking statements, together with statements made pursuant to the protected harbor provisions of the Personal Securities Litigation Reform Act of 1995. These statements could also be recognized by phrases comparable to “goals,” “anticipates,” “believes,” “may,” “estimates,” “expects,” “forecasts,” “aim,” “intends,” “might,” “plans,” “potential,” “potential,” “seeks,” “will,” and variations of those phrases or related expressions which might be meant to establish forward-looking statements. Any such statements on this press launch that aren’t statements of historic reality could also be deemed to be forward-looking statements. Any forward-looking statements on this press launch are based mostly on the Firm’s present expectations, estimates and projections solely as of the date of this launch and are topic to quite a lot of dangers and uncertainties that would trigger precise outcomes to vary materially and adversely from these set forth in or implied by such forward-looking statements. Though the Firm believes that the expectations expressed in these forward-looking statements are affordable, it can not guarantee you that such expectations will develop into right, and the Firm cautions traders that precise outcomes might differ materially from the anticipated outcomes and encourages traders to assessment different components which will have an effect on its future outcomes set forth within the Firm’s annual report on Type 20-F and different paperwork filed by the Firm with the U.S. Securities and Alternate Fee. The Firm explicitly disclaims any obligation to replace any forward-looking statements besides to the extent required by regulation.
For extra data, please contact:
WORK Medical Know-how Group LTD
Investor Relations Division
Electronic mail:
[email protected]
Ascent Investor Relations LLC
Tina Xiao
Telephone: +1-646-932-7242
Electronic mail:
[email protected]
